- call +1-201-465-4211
- email sales@mrinsights.biz
Sinusitis, also known as a sinus infection or rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts less than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks. Drugs for Sinusitis are common in the market, and the drugs can also be used in other disease. These drugs can not cure sinusitis, can only relieve symptoms.
Scope of the Report:
The classification of Drugs for Sinusitis includes Antibiotics, Corticosteroids, Decongestants and other. And the revenue proportion of Corticosteroids in 2015 is nearly 31%.
Drugs for Sinusitis are widely used in Neurology, Orthopedics, Musculoskeletal &Spine, Cardiology & Vascular, Skin & Integumentary, and other field. The most proportion of Drugs for Sinusitis is Orthopedics, Musculoskeletal &Spine, and the revenue in 2015 is 2387.4 M USD.
North America region is the largest supplier of Drugs for Sinusitis, with a revenue market share nearly 35% in 2015. Europe is the second largest supplier of Drugs for Sinusitis, enjoying revenue market share nearly 27% in 2015.
North America is the largest consumption place, with a consumption market share nearly 35% in 2015. Following North America, Europe is the second largest consumption place with the consumption market share of 24%.
Sanofi, Bayer AG, Pfizer etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
The worldwide market for Drugs for Sinusitis is expected to grow at a CAGR of roughly 3.6% over the next five years, will reach 2410 million US$ in 2024, from 1950 million US$ in 2019, according to a new study.
This report focuses on the Drugs for Sinusitis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Sanofi
Bayer AG
Pfizer
AstraZeneca Plc
Novartis AG.
Johnson & Johnson
Merck
Amgen
Bionorica SE
Dr. Reddy's Laboratories
Huasun
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antibiotics
Corticosteroids
Decongestants
Market Segment by Applications, can be divided into
Acute Sinusitis
Chronic Sinusitis
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for Sinusitis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drugs for Sinusitis, with price, sales, revenue and global market share of Drugs for Sinusitis in 2017 and 2018.
Chapter 3, the Drugs for Sinusitis competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Sinusitis breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Drugs for Sinusitis market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Drugs for Sinusitis sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Drugs for Sinusitis Introduction
1.2 Market Analysis by Type
1.2.1 Antibiotics
1.2.2 Corticosteroids
1.2.3 Decongestants
1.3 Market Analysis by Applications
1.3.1 Acute Sinusitis
1.3.2 Chronic Sinusitis
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Drugs for Sinusitis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Drugs for Sinusitis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bayer AG
2.2.1 Business Overview
2.2.2 Drugs for Sinusitis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer AG Drugs for Sinusitis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Drugs for Sinusitis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Drugs for Sinusitis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 AstraZeneca Plc
2.4.1 Business Overview
2.4.2 Drugs for Sinusitis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AstraZeneca Plc Drugs for Sinusitis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Novartis AG.
2.5.1 Business Overview
2.5.2 Drugs for Sinusitis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis AG. Drugs for Sinusitis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Drugs for Sinusitis Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Drugs for Sinusitis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Merck
2.7.1 Business Overview
2.7.2 Drugs for Sinusitis Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Drugs for Sinusitis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Amgen
2.8.1 Business Overview
2.8.2 Drugs for Sinusitis Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Amgen Drugs for Sinusitis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Bionorica SE
2.9.1 Business Overview
2.9.2 Drugs for Sinusitis Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bionorica SE Drugs for Sinusitis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Dr. Reddy's Laboratories
2.10.1 Business Overview
2.10.2 Drugs for Sinusitis Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Dr. Reddy's Laboratories Drugs for Sinusitis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Huasun
2.11.1 Business Overview
2.11.2 Drugs for Sinusitis Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Huasun Drugs for Sinusitis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Drugs for Sinusitis Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Drugs for Sinusitis Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Drugs for Sinusitis Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Drugs for Sinusitis Manufacturer Market Share in 2018
3.3.2 Top 6 Drugs for Sinusitis Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Drugs for Sinusitis Market Analysis by Regions
4.1 Global Drugs for Sinusitis Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Sinusitis Sales and Market Share by Regions (2014-2019)
4.1.2 Global Drugs for Sinusitis Revenue and Market Share by Regions (2014-2019)
4.2 North America Drugs for Sinusitis Sales and Growth Rate (2014-2019)
4.3 Europe Drugs for Sinusitis Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Drugs for Sinusitis Sales and Growth Rate (2014-2019)
4.5 South America Drugs for Sinusitis Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Drugs for Sinusitis Sales and Growth Rate (2014-2019)
5 North America Drugs for Sinusitis by Country
5.1 North America Drugs for Sinusitis Sales, Revenue and Market Share by Country
5.1.1 North America Drugs for Sinusitis Sales and Market Share by Country (2014-2019)
5.1.2 North America Drugs for Sinusitis Revenue and Market Share by Country (2014-2019)
5.2 United States Drugs for Sinusitis Sales and Growth Rate (2014-2019)
5.3 Canada Drugs for Sinusitis Sales and Growth Rate (2014-2019)
5.4 Mexico Drugs for Sinusitis Sales and Growth Rate (2014-2019)
6 Europe Drugs for Sinusitis by Country
6.1 Europe Drugs for Sinusitis Sales, Revenue and Market Share by Country
6.1.1 Europe Drugs for Sinusitis Sales and Market Share by Country (2014-2019)
6.1.2 Europe Drugs for Sinusitis Revenue and Market Share by Country (2014-2019)
6.2 Germany Drugs for Sinusitis Sales and Growth Rate (2014-2019)
6.3 UK Drugs for Sinusitis Sales and Growth Rate (2014-2019)
6.4 France Drugs for Sinusitis Sales and Growth Rate (2014-2019)
6.5 Russia Drugs for Sinusitis Sales and Growth Rate (2014-2019)
6.6 Italy Drugs for Sinusitis Sales and Growth Rate (2014-2019)
7 Asia-Pacific Drugs for Sinusitis by Country
7.1 Asia-Pacific Drugs for Sinusitis Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Drugs for Sinusitis Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Drugs for Sinusitis Revenue and Market Share by Country (2014-2019)
7.2 China Drugs for Sinusitis Sales and Growth Rate (2014-2019)
7.3 Japan Drugs for Sinusitis Sales and Growth Rate (2014-2019)
7.4 Korea Drugs for Sinusitis Sales and Growth Rate (2014-2019)
7.5 India Drugs for Sinusitis Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Drugs for Sinusitis Sales and Growth Rate (2014-2019)
8 South America Drugs for Sinusitis by Country
8.1 South America Drugs for Sinusitis Sales, Revenue and Market Share by Country
8.1.1 South America Drugs for Sinusitis Sales and Market Share by Country (2014-2019)
8.1.2 South America Drugs for Sinusitis Revenue and Market Share by Country (2014-2019)
8.2 Brazil Drugs for Sinusitis Sales and Growth Rate (2014-2019)
8.3 Argentina Drugs for Sinusitis Sales and Growth Rate (2014-2019)
8.4 Colombia Drugs for Sinusitis Sales and Growth Rate (2014-2019)
9 Middle East and Africa Drugs for Sinusitis by Countries
9.1 Middle East and Africa Drugs for Sinusitis Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Drugs for Sinusitis Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Drugs for Sinusitis Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Drugs for Sinusitis Sales and Growth Rate (2014-2019)
9.3 Turkey Drugs for Sinusitis Sales and Growth Rate (2014-2019)
9.4 Egypt Drugs for Sinusitis Sales and Growth Rate (2014-2019)
9.5 Nigeria Drugs for Sinusitis Sales and Growth Rate (2014-2019)
9.6 South Africa Drugs for Sinusitis Sales and Growth Rate (2014-2019)
10 Global Drugs for Sinusitis Market Segment by Type
10.1 Global Drugs for Sinusitis Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Drugs for Sinusitis Sales and Market Share by Type (2014-2019)
10.1.2 Global Drugs for Sinusitis Revenue and Market Share by Type (2014-2019)
10.2 Antibiotics Sales Growth and Price
10.2.1 Global Antibiotics Sales Growth (2014-2019)
10.2.2 Global Antibiotics Price (2014-2019)
10.3 Corticosteroids Sales Growth and Price
10.3.1 Global Corticosteroids Sales Growth (2014-2019)
10.3.2 Global Corticosteroids Price (2014-2019)
10.4 Decongestants Sales Growth and Price
10.4.1 Global Decongestants Sales Growth (2014-2019)
10.4.2 Global Decongestants Price (2014-2019)
11 Global Drugs for Sinusitis Market Segment by Application
11.1 Global Drugs for Sinusitis Sales Market Share by Application (2014-2019)
11.2 Acute Sinusitis Sales Growth (2014-2019)
11.3 Chronic Sinusitis Sales Growth (2014-2019)
12 Drugs for Sinusitis Market Forecast (2019-2024)
12.1 Global Drugs for Sinusitis Sales, Revenue and Growth Rate (2019-2024)
12.2 Drugs for Sinusitis Market Forecast by Regions (2019-2024)
12.2.1 North America Drugs for Sinusitis Market Forecast (2019-2024)
12.2.2 Europe Drugs for Sinusitis Market Forecast (2019-2024)
12.2.3 Asia-Pacific Drugs for Sinusitis Market Forecast (2019-2024)
12.2.4 South America Drugs for Sinusitis Market Forecast (2019-2024)
12.2.5 Middle East and Africa Drugs for Sinusitis Market Forecast (2019-2024)
12.3 Drugs for Sinusitis Market Forecast by Type (2019-2024)
12.3.1 Global Drugs for Sinusitis Sales Forecast by Type (2019-2024)
12.3.2 Global Drugs for Sinusitis Market Share Forecast by Type (2019-2024)
12.4 Drugs for Sinusitis Market Forecast by Application (2019-2024)
12.4.1 Global Drugs for Sinusitis Sales Forecast by Application (2019-2024)
12.4.2 Global Drugs for Sinusitis Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Drugs for Sinusitis Picture
Table Product Specifications of Drugs for Sinusitis
Figure Global Sales Market Share of Drugs for Sinusitis by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
